Binuclear VIV/V, MoVI and ZnII - hydroquinonate complexes: Synthesis, stability, oxidative activity and anticancer properties
作者:Maria Loizou、Petri Papaphilippou、Manolis Vlasiou、Maria Spilia、Dimitrios Peschos、Yannis V. Simos、Anastasios D. Keramidas、Chryssoula Drouza
DOI:10.1016/j.jinorgbio.2022.111911
日期:2022.10
activity towards their anticancer properties on various cancerous and non-cancerous cell lines has been evaluated. The new complexes of ZnII with the ligands 2,5-bis((bis(pyridin-2-ylmethyl)amino)methyl)benzene-1,4-diol (H2bpymah) and 2,2′-(((2,5-dihydroxy-1,4-phenylene)bis(methylene))bis((carboxymethyl)ammoniumdiyl))diacetate (H6bicah) have been synthesized and characterized by X-ray crystallography in
自从发现顺铂的抗癌特性以来,开辟了开发毒性更小、特异性更强的基于金属离子的抗癌药物的道路。基于 V IV/V、Mo VI和 Zn II金属离子的低毒性,合成了它们的双核氢醌酸盐络合物,并评估了它们对各种癌细胞系和非癌细胞系的抗癌特性的生物活性。Zn II与配体 2,5-bis((bis(pyridin-2-ylmethyl)amino)methyl)benzene-1,4-diol (H 2 bpymah) 和 2,2'-(((2 ,5-dihydroxy-1,4-phenylene)bis(methylene))bis((carboxymethyl)ammoniumdiyl))diacetate (H 6bicah) 已合成并通过固态 X 射线晶体学和水溶液中的1 H NMR 表征。复合物的双核性质增加了它们在 pD 7.0 的水溶液中的水解稳定性,具体取决于金属离子。水解最稳定的 VV和Zn